| Sign In to gain access to subscriptions and/or personal tools. |
Arsenic-Induced Decreases in the Vascular Matrix
1 Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, USA Correspondence: Allison M. Hays, Ph.D., University of Arizona College of Pharmacy, P.O. Box 210207, Tucson, AZ 85721-0207, USA; e-mail:hays{at}email.arizona.edu.
Chronic ingestion of arsenic is associated with increased incidence of respiratory and cardiovascular diseases. To investigate the role of arsenic in early events in vascular pathology, C57BL/6 mice ingested drinking water with or without 50 ppb sodium arsenite (AsIII) for four, five, or eight weeks. At five and eight weeks, RNA from the lungs of control and AsIII-exposed animals was processed for microarray. Sixty-five genes were significantly and differentially expressed. Differential expression of extracellular matrix (ECM) gene transcripts was particularly compelling, as 91% of genes in this category, including elastin and collagen, were significantly decreased. In additional experiments, real-time RT-PCR showed an AsIII-induced decrease in many of these ECM gene transcripts in the heart and NIH3T3 fibroblast cells. Histological stains for collagen and elastin show a distinct disruption in the ECM surrounding small arteries in the heart and lung of AsIII-exposed mice. Immunohistochemical detection of -smooth muscle actin in blood vessel walls was decreased in the AsIII-exposed animals. These data reveal a functional link between AsIII exposure and disruption in the vascular ECM. These AsIII-induced early pathological events may predispose humans to respiratory and cardiovascular diseases linked to chronic low-dose AsIII exposure.
Key Words: arsenic cardiovascular system environmental toxicology microarray genomics immunohistochemistry lung vascular system Abbreviations: Alas-1, aminolevulinate acid synthase AsIII, sodium arsenite BFD, blackfoot disease Col1a1, collagen 1a1 Col1a2, collagen 1a2 Col6a3, collagen 6a3 Col6a2, collagen 6a2 Col3a1, collagen 3a1 Col4a1, collagen 4a1 Eln, elastin Fbn1, fibrillin-1 Fbln1, fibulin-1 Fn1, fibronectin 1 GST, glutathione-S-transferase Has2, hyaluronan acid synthase-2 Lox1, lysyl oxidase 1 Lum, lumican Mfap5, microfibrillar associated protein 5 ppb, parts per billion redox, reduction-oxidation RMA, Robust MultiChip Analysis SAM, Statistical Analysis of Microarrays
It has recently been appreciated that chronic ingestion of arsenic can lead to cardiovascular and respiratory toxicity with a resulting plethora of diseases, including chronic bronchitis, obstructive pulmonary disease, interstitial lung disease, and bronchiectasis (Mazumder 2007); and peripheral vascular disease, atherosclerosis, coronary artery disease, myocardial infarction, ischemic heart disease, and diabetes (Chang et al. 2004; Tseng et al. 2003). Specifically, in diabetes, disregulation of matrix metabolism has been shown to contribute to arsenic-induced vasculopathies (Cooper et al. 2001). Diabetes is commonly associated with both microvascular and macrovascular complications. Expression of growth factors is stimulated in the vasculature in response to this disease, which leads to extracellular matrix accumulation in the diabetic kidney (Cooper et al. 2001). In contrast to this finding, we found a decrease in extracellular matrix transcripts in the lung, heart, and NIH3T3 cells in response to sodium arsenite (AsIII). The mechanism(s) associated with these various arsenic-mediated cardiovascular and respiratory pathologies remains elusive. The majority of biological models of arsenic exposure implicate aberrations in cell proliferation, oxidative damage, and DNA-repair fidelity in arsenic-mediated carcinogenicity and toxicity (Li et al. 2002; Schwerdtle et al. 2003; Yuan et al. 2003). The purpose of this investigation is to determine whether exposure to low concentrations of AsIII can cause early changes in the cardiovasculature, which can lead to the development of cardiovascular diseases. The large majority of in vivo arsenic studies involve acute time courses and/or high exposure levels. Chronic low-dose arsenic studies in animals are almost nonexistent. The few animal studies that do investigate the chronic, low-dose protocol demonstrate arsenic-associated angiogenic effects (Soucy et al. 2003); increased metastases of tumors to the lung (Kamat et al. 2005); increased oxidative stress (Hughes and Thompson 1996); differential gene expression of cytokines and steroid-, apoptosis-, and cell-cycle–related genes (Chen et al. 2004); and differential gene expression of genes associated with cell growth (Simeonova et al. 2000). Epidemiology studies from Taiwan link human arsenic exposure to a wide variety of cardiovascular and lung-associated diseases (Chang et al. 2004; Guo et al. 1997). In Taiwan, one of the most studied geographical areas with respect to arsenic in well water, this metal induces blackfoot disease (BFD), a severe form of peripheral vascular disease, in which damage to the blood vessels in the lower limbs results in progressive gangrene. Human studies from BFD-hyperendemic villages are characterized by long-term exposure to well water with high levels of arsenic. In addition to BFD, squamous and small cell lung carcinomas (Guo et al. 2004); ischemic heart disease (Chang et al. 2004; Tseng et al. 2003); carotid atherosclerosis (Wang et al. 2002); cerebrovascular disease and diabetes mellitus (Tsai et al. 1999); and inflammation and oxidative stress (Wang et al. 2003) were significantly associated with arsenic exposure in a dose-response relationship in these villages. In addition to studies in Taiwan, investigations from around the world demonstrate that arsenic exposure is associated with cardiovascular and respiratory pathologies. Acute and chronic arsenic exposure via drinking water has been reported in Chile, Bangladesh, India, Argentina, Mexico, and Thailand (Ferreccio and Sancha 2006). In these areas, general health effects that are associated with arsenic exposure include lung cancer, cardiovascular and peripheral vascular disease, developmental anomalies, diabetes, lung fibrosis, and hematologic disorders (Nabi et al. 2005; Rahman et al. 2001; Tchounwou et al. 1999). Collectively, these studies demonstrate the vascular and respiratory health consequences observed around the world in people exposed to arsenic. Findings from epidemiologic studies among populations exposed to lower levels of arsenic (< 100 parts per billion [ppb]) are mixed and generally do not reveal risks of bladder, lung, or other cancers that would be expected from extrapolation of results from the high-exposure studies. When errors in assessment of low exposure are made, about half of the actual risk increase is missed. Thus, bladder cancer studies conducted in populations exposed to low levels of arsenic are limited because of this problem (Bates et al. 1995; Bates et al. 2004; Karagas et al. 2004; Kurttio et al. 1999; Steinmaus et al. 2003). In addition, characterizing past low-dose exposure in detail is challenging, especially in shifting populations in the United States (Bates et al. 1995; Karagas et al. 2004; Steinmaus et al. 2003). The term reduction–oxidation (redox) state is often used to describe the balance of redox pairs (for example, the glutathione system) in a biological system, which if not balanced, results in oxidative stress. Gene transcripts involved in oxidative stress have been found to be increased in people exposed to arsenic (Wang et al. 2003). Oxidative stress is produced by endothelial, smooth muscle, and fibroblast cells in response to arsenic (Barchowsky et al. 1996; Bau et al. 2002; Bunderson et al. 2002; Lynn et al. 2000; Wang et al. 1997; Yang et al. 2007; Yeh et al. 2002; Yih et al. 2002). Oxidative stress and the resultant disregulation of the extracellular matrix have been linked to both cancer and atherosclerosis through a series of common molecular pathways, which play a significant role in the pathogenesis and progression of these two diseases (Ross et al. 2001).
To investigate the molecular targets involved in long-term, low-dose, arsenic-associated cardiovascular and respiratory toxicity, we conducted a study using Affymetrix mouse 430(A) arrays. Using microarrays, we were able to identify genes with differential expression in the lungs of AsIII-exposed (50 ppb) and control C57BL/6 mice. Hearts were also harvested, and real-time RT-PCR demonstrated an AsIII-associated decrease in the levels of expression of many of the same extracellular matrix genes found to be decreased in the lung. This result was also supported in vitro by using murine embryonic fibroblasts (NIH3T3 cells) exposed to AsIII. The decrease in the extracellular matrix gene transcripts compelled us to investigate the vasculature. In the extravascular matrix of small arteries in the lung and heart, collagen and elastic fiber density and integrity were decreased in the arsenic-exposed groups as compared to controls. The staining for
Animals Adult C57BL/6 mice were housed in the AAALAC-approved University of Arizona Health Sciences Center animal facility. The animal protocol was approved by the University of Arizona Institutional Animal Care and Use Committee. Animals were housed four mice per cage and fed ad libitum with either normal drinking water or water containing 50 ppb AsIII as sodium arsenite (NaAsO2) (Sargent-Welch, Tonawanda, NY, USA) for four, five, or eight weeks.
Cell Culture
Affymetrix GeneChip System
Real-Time RT-PCR Analysis A different protocol was used for real-time RT-PCR analysis of collagen 1a1 (Col1a1), collagen 1a2 (Col1a2), collagen 3a1 (Col3a1), collagen 4a1 (Col4a1), fibronectin (Fn1), fibulin (Fbln1), microfibrillar associated protein 5 (Mfap5), hyaluronan acid synthase-2 (Has2), and elastin (Eln) gene expression in the heart and NIH3T3 murine embryonic fibroblasts. RNA was isolated and a reverse transcription step was performed using 1 µg of total RNA in a 20 µl reaction and the Transcriptor First Strand cDNA Synthesis Kit (Roche Applied Science, Indianapolis, IN, USA). The reverse transcription reaction was primed with oligo dTs and incubated at 65°C for ten minutes followed by 50°C for sixty minutes, 85°C for five minutes, and finally, 4°C until retrieved. Each real-time PCR reaction consisted of 2 µl of cDNA added to 4 µl of Roche Universal PCR Master Mix (Roche Applied Science, Indianapolis, IN, USA), 2 µl of gene-specific primer/probe mix (Universal Probe Library, Roche Applied Science, Indianapolis, IN, USA), and 12 µl of PCR water. The gene-specific probes are from the Universal Probe Library (UPL) (Roche Applied Science, Indianapolis, IN, USA). These probes are labeled with the 5' reporter dye, 6-FAM, and a 3' end that contains a nonfluorescent quencher and a minor groove binder to bind to the cDNA. The real-time PCR conditions were 95°C for ten minutes, followed by 40 cycles of 95°C for fifteen seconds alternating with 60°C for one minute. Data were collected using the LightCycler 2.0 detection system (Roche Applied Science, Indianapolis, IN, USA). To determine relative amounts of transcript between samples, the relative quantification method was used. The relative starting amount of each sample was determined by normalizing the crossing point (Cp) of the extracellular matrix gene-of-interest to the Cpof the reference molecule aminolevulinate acid synthase (Alas-1) (Roche Applied Science, Indianapolis, IN, USA). A calibrator was used to arrive at a normalized ratio (LightCycler software 4.0). Primer sequences are available in Table II of the supplementary data (please refer to http://tpx.sagepub.com/supplemental).
Histology
Analysis of Vascular Wall Complexity
Immunohistochemistry
Computed Morphometric Analysis
Significant Gene Expression Changes Grouped by Function Changes in gene expression in the lungs of mice exposed to arsenic for five and eight weeks were grouped by function using information provided in the gene ontology (GO) annotation for each gene. GO categories include: receptors, transcriptional, signal transduction, chaperones, immunological, cell cycle, enzymes, cytokines (Table 1), and structural (Figure 1). Sixty-five genes were observed to be significantly increased or decreased in both the five- and eight-week AsIII-treated groups. These genes were ranked by pvalue, and the ones with pvalues < .0001 are listed in Table I of the supplementary data (please refer to http://tpx.sagepub.com/supplemental). The majority of these genes in the AsIII-exposed group were decreased in comparison to controls.
Decrease in Extracellular Matrix Genes in Response to AsIII The majority (91%) of the extracellular matrix (ECM) genes, a subcategory of the structural genes, were decreased in the AsIII-treated animals as compared to controls (Figure 1, boxed genes). These include genes encoding for Eln, Mfap5, Lum, Col1a1, Col1a2, Col6a3, Col6a2, Col3a1, Col4a1, and Fn1. Other genes related to the extracellular matrix that showed a decrease in expression include Fbn1, Fbln1, and the enzyme involved in collagen and elastin processing, lysyl oxidase 1 (Lox1) (Table 1). All of these genes play a major role in extra-cellular matrix homeostasis.
Increase in Redox-Sensitive Genes in Response to AsIII
AsIII Exposure Decreases Extracellular Matrix Gene Transcript Expression in Fibroblasts
AsIII Exposure Decreases Extracellular Matrix Gene Transcript Expression in the Heart To investigate the possibility that AsIII affects the heart in a manner similar to the lung, hearts were harvested from control and AsIII-exposed (50 ppb, eight weeks) mice. Total RNA was isolated, and real-time RT-PCR analysis was performed for Col1a1, Col1a2, Col3a1, Col4a1, Fn1, Eln, Fbn1, Mfap5, and Has2 (Figure 3). In all cases, the values demonstrate significant decreases in transcription levels for these genes similar to that observed in the fibroblasts. This finding is consistent with the decreases in gene transcription found in the lungs of animals exposed to AsIII.
Disrupted Extracellular Matrix Deposition in Blood Vessels Exposed to AsIII The extracellular matrix is critical for maintaining the integrity of the vasculature, so we used histological stains for collagen in the lung (Figures 4A and 4B) and heart (Figures 5G and 5H) and elastin in the lung (Figures 4C and 4D) and heart (Figures 5C and 5D) to highlight the morphological significance of the decrease in these gene transcripts in response to 50 ppb AsIII as compared to control. This morphological significance is seen dramatically in the vascular matrix. The vascular wall is composed of three cell types: endothelial cells (tunica intima), smooth muscle cells (tunica media), and fibroblasts (tunica adventitia) (Hallmann et al. 2005; Saharinen et al. 1999). Elastin staining shows the internal and external elastic laminae of control arteries in the lung (Figure 4C) and heart (Figure 5C) to be intact, whereas the elastic laminae are considerably less well defined, and in parts of the wall, nonexistent in the 50 ppb vessels in the lung (Figure 4D) and heart (Figure 5D). In the lung, the detection of collagen shows a disrupted and considerably less dense tunica adventitia in small arteries in the 50 ppb (Figure 4B) animals compared to controls (Figure 4A). In the heart, collagen deposition is also disrupted, and there is considerably less dense tunica adventitia in small arteries in the 50 ppb-exposed animals (Figure 5H) compared to controls (Figure 5G). In arteriolar walls, the collagen fibers are frayed, and some fibers may have lost some length as compared to the controls. These results were observed in all three animals exposed to AsIII. These histological stains for elastin and collagen demonstrate the association between the decrease in extracellular matrix gene transcription in organs of arsenic-treated animals and the morphological significance of this decrease on the vascular matrix in these organs.
Analysis of Vascular Wall Complexity Using heart tissue stained with Massons Trichrome for collagen, ten random images of blood vessels from each treatment group (control and 50 ppb AsIII) were selected, and four independent researchers described what they observed to be different and/or the same between groups. In general, they described the control blood vessels in the heart as having a structured collagen network present in the extravascular matrix. In the control tissue, most blood vessel walls contained fairly dense collagen fibers, whereas only a few walls showed scant or loose collagen production. In contrast, they described the AsIII treated blood vessel walls to be surrounded by a dilated extravascular space with little evidence of a structured collagen network, that is, there was scant collagen present. In the AsIII-treated tissue, some blood vessel walls contained collagen fiber networks similar to control tissue, whereas many walls showed scant or loose collagen production.
Decrease in Detection of Anti-
Computed Morphometric Analysis
The mechanism(s) of arsenic-induced cardiorespiratory disease is not known. We used gene expression analysis along with complimentary histological and immunohistochemical approaches to correlate differential gene expression and morphological changes in the vascular matrix after exposure to environmentally relevant concentrations of arsenic. Signaling mechanisms affecting gene transcription could be modulated by AsIII. This modulation could be the result of interaction with proteins containing a critical cysteine that is in a vicinal dithiol grouping with a second cysteine. It is known that the stability of these complexes is favored by the exothermic formation of AsIII–thiolate bonds (Spuches et al. 2005). The dithiol complexing ability of AsIII allows it to act as an oxidizing agent, thus creating oxidative stress. For example, activation of NF- B depends on the integrity of the I B kinase (IKK) complex, which is inhibited by AsIII binding to Cys-179 in the activation loop of IKK (Kapahi et al. 2000). Arsenite has also been shown to inhibit DNA repair of oxidative damage by interaction with vicinal dithiols of DNA ligase and Poly(ADP-ribose) polymerase (PARP) (Lynn et al. 1997; Yager and Wiencke 1997). Oxidative stress has been implicated in arsenic-associated respiratory and cardiovascular diseases (Bunderson et al. 2002; Han et al. 2005). Because arsenic is a known oxidant stressor, we would expect AsIII to increase redox-sensitive genes. The redox-sensitive gene transcripts that are increased in the lungs of animals exposed for both five and eight weeks include heat shock and stress proteins (Table 1) and glutathione metabolizing enzymes (unpublished data). These enzymes include: glutathione-S-transferase- 2 (GST- 2), GST- 3, and glutathione reductase (a 2.3-fold increase compared to controls). Of particular interest to us in this study are the extracellular matrix molecules collagen and elastin. In the matrix, the collagen isoforms include type I (tensile strength), type III (subendothelium), type IV (basal lamina), and type VI (bridges cells with extracellular matrix). In addition, type I and III collagens are the main extracellular matrix components of the lung (Crystal and West 1997), and they are involved in wound healing (Van Hoozen et al. 2000). Studies of genetic defects in collagen and collagen-associated molecules aid in understanding the phenotypic consequences of decreases in collagen gene transcription, which can be observed in genetic diseases affecting the vasculature. Aortic aneurysms are a consequence of Marfans syndrome, which is associated with defects in fibrillin and type I collagen assembly (Whiteman et al. 2006). Altered blood vessel stability is the result of collagen defects in both osteogenesis imperfecta and Ehlers-Danlos syndrome (Kuznetsova et al. 2004). As demonstrated in the present study, AsIII-associated decreases in collagen and fibrillin may mimic the collagen-related syndromes, resulting in a disrupted blood vessel structure. Because arsenic has a high affinity for vicinal dithiols (Rey et al. 2004), it is important to note that collagen production is regulated by molecules that contain vicinal dithiols. These include: epidermal growth factor (EGF) (Saharinen et al. 1999), the transcription factor c-Krox (Galera et al. 1994; Karsenty and Park 1995), and N-propeptides, which control collagen fibril shape (Wu et al. 1991). It is possible that the decrease in collagen transcription was in part mediated by its interaction with the vicinal dithiols of molecules that modulate collagen production. Further research is needed to confirm the interaction of arsenic with cysteine-rich molecules in this context. Because exposure to ingested arsenic is associated with increased risk for various vasculopathies (Soucy et al. 2004; Tseng 2002; Yang et al. 2005), we focused on important extravascular components. We used Massons Trichrome stain to highlight the destabilized and disorganized collagenous tunica adventitia in arteries of both the lung and heart in the 50 ppb group (Figures 4Aand 5G) as compared to controls (Figures 4Band 5H). In addition, a blinded subjective analysis of vascular wall complexity in the heart using Massons Trichrome stain for collagen was performed. This is an excellent method to obtain a large amount of information, as it is easy to make out the extensive collagenous fiber reinforcement of the blood vessel wall, and most aspects of vessel wall pathology can be appreciated. In the control tissue, most blood vessel walls contained fairly dense collagen fibers; in contrast, the AsIII-treated blood vessel walls were surrounded by a dilated extravascular space with little evidence of a structured collagen network.
Taken together, the gene expression and histological studies reveal that collagen and collagen-related gene transcript levels and subsequent collagen disorganization in the arteriolar wall are affected by an environmentally relevant level of arsenic that may predispose exposed individuals to vascular pathologies in general. In addition to collagen, microarray analysis and subsequent real-time analysis (data not shown) revealed that in response to 50 ppb AsIII, elastin gene transcription was decreased in the lung (Figure 1) and heart (Figure 3). Elastin is a major component of the extravascular matrix, and elastin fiber assembly employs elastin microfibril-associated proteins. These proteins include microfibril associated protein-5 and the fibulins and fibrillins, which are a family of secreted adhesive glycoproteins that link cells to the elastic fibers of the extracellular matrix (Freeman et al. 2005; Saharinen et al. 1999). Histological analysis demonstrated that compared to controls, elastin staining is disrupted in the extravascular matrix of arteries in the lung and heart of mice exposed to 50 ppb AsIII (Figures 4C–Dand 5C–D). Because the study of elastin knockout mice reveals elastin to be a major developmental regulator of the vascular smooth muscle cell life cycle and organization (Faury 2001), we looked at Immunohistochemical analysis also demonstrated a disruption in the elastic lamellae of the tunica media at 50 ppb AsIII as compared to controls (Figure 5A and 5B). Computed morphometric analysis of elastic fibers in lungs from AsIII-treated animals was performed and compared with data obtained from control animals. Image analysis demonstrated that on average, elastic fibers constituted 38.9% of the total tissue in the 50 ppb-treated group and 56.0% in control lungs. Thus, elastin volume density in the lung in AsIII-exposed animals was less than in control lungs. This morphometric analysis confirms that there are significant differences in elastic fiber density between AsIII-treated and control mice and that 50 ppb AsIII causes abnormal patterns of elastin expression and accumulation. Because elastic fibers give blood vessels important properties, such as elastic recoil, the clinical relevance of AsIII-dependent disruption of elastic fibers would be a progressive impairment of their function with a concomitant production of circulating elastin peptides, which could potentially be measured with a blood test.
Our results provide new insight into the arsenic-associated effects on smooth muscle cells of blood vessel walls. Our observation of altered arteriolar matrix with decreased Data presented here are the first to demonstrate the arsenic-associated correlation between genomics, histology, and immunohistochemistry and its disruptive effects in vivo on blood vessels in the lung and heart. These changes are occurring at environmentally relevant, long-term exposure levels. When analyzed in the context of a decrease in critical extracellular matrix gene transcripts (collagen, Eln, Fn1, Lox1, Mfap-5, Has2, Fbln1, and Fbn1), the results suggest a mechanism for arsenic-induced respiratory and cardiovascular pathologies. This mechanism includes both interruption of gene transcription and direct disruption of extracellular matrix components in blood vessels in target organs of arsenic toxicity. Analysis of the molecular mechanisms of altered matrix expression will further our understanding of the sites of action of arsenic.
This research was supported in part by an NIH/NIEHS Superfund grant, P42 ES04940, and by an NIH/NIEHS Center grant, P30 ES006694. Thanks to Doug Cromey and Mark Stevens for their technical expertise.
Barchowsky, A, Dudek, EJ, Treadwell, MD, & Wetterhahn, KE. (1996). Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells. Free Radic Biol Med, 21, 783-90[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Bates, MN, Rey, OA, Biggs, ML, Hopenhayn, C, Moore, LE, Kalman, D, Steinmaus, C, & Smith, AH. (2004). Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol, 159, 381-89 Bates, MN, Smith, AH, & Cantor, KP. (1995). Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol, 141, 523-30 Bau, DT, Wang, TS, Chung, CH, Wang, AS, Wang, AS, & Jan, KY. (2002). Oxidative DNA adducts and DNA-protein cross-links are the major DNA lesions induced by arsenite. Environ Health Perspect 110 Suppl, 5, 753-56 Bunderson, M, Coffin, JD, & Beall, HD. (2002). Arsenic induces peroxynitrite generation and cyclooxygenase-2 protein expression in aortic endothelial cells: possible role in atherosclerosis. Toxicol Appl Pharmacol, 184, 11-18[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Chang, CC, Ho, SC, Tsai, SS, & Yang, CY. (2004). Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system. J Toxicol Environ Health A, 67, 1353-61[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Chen, H, Li, S, Liu, J, Diwan, BA, Barrett, JC, & Waalkes, MP. (2004). Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis, 25, 1779-86 Crystal, RG, & West, JD. (1997). The Lung. New York: Raven Press, Ltd Cooper, ME, Bonnet, F, Oldfield, M, & Jandeleit-Dahm, K. (2001). Mechanisms of diabetic vasculopathy: an overview. Am J Hypertens, 14, 475-86[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Engel, RR, Hopenhayn-Rich, C, Receveur, O, & Smith, AH. (1994). Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev, 16, 184-209 Faury, G. (2001). [Role of elastin in the development of vascular function. Knock-out study of the elastin gene in mice]. Journal de la Societe de biologie, 195, 151-56[Medline] [Order article via Infotrieve] Ferreccio, C, & Sancha, AM. (2006). Arsenic exposure and its impact on health in Chile. J Health Popul Nutr, 24, 164-75[Web of Science][Medline] [Order article via Infotrieve] Freeman, LJ, Lomas, A, Hodson, N, Sherratt, MJ, Mellody, KT, Weiss, AS, Shuttleworth, A, & Kielty, CM. (2005). Fibulin-5 interacts with fibrillin-1 molecules and microfibrils. Biochem J, 388, 1-5[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Galera, P, Musso, M, Ducy, P, & Karsenty, G. (1994). c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. Proc Natl Acad Sci U S A, 91, 9372-76 Guo, HR, Chiang, HS, Hu, H, Lipsitz, SR, & Monson, RR. (1997). Arsenic in drinking water and incidence of urinary cancers. Epidemiology, 8, 545-50[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Guo, HR, Wang, NS, Hu, H, & Monson, RR. (2004). Cell type specificity of lung cancer associated with arsenic ingestion. Cancer Epidemiol Biomarkers Prev, 13, 638-43 Hallmann, R, Horn, N, Selg, M, Wendler, O, Pausch, F, & Sorokin, LM. (2005). Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev, 85, 979-1000 Han, SS, Kim, K, Hahm, ER, Park, CH, Kimler, BF, Lee, SJ, Lee, SH, Kim, WS, Jung, CW, Park, K, Kim, J, Yoon, SS, Lee, JH, & Park, S. (2005). Arsenic trioxide represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60. J Cell Biochem, 94, 695-707[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Hughes, MF, & Thompson, DJ. (1996). Subchronic dispositional and toxicological effects of arsenate administered in drinking water to mice. J Toxicol Environ Health, 49, 177-96[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Kamat, CD, Green, DE, Curilla, S, Warnke, L, Hamilton, JW, Sturup, S, Clark, C, & Ihnat, MA. (2005). Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration. Toxicol Sci, 86, 248-57 Kapahi, P, Takahashi, T, Natoli, G, Adams, SR, Chen, Y, Tsien, RY, & Karin, M. (2000). Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase. J Biol Chem, 275, 36062-66 Karagas, MR, Tosteson, TD, Morris, JS, Demidenko, E, Mott, LA, Heaney, J, & Schned, A. (2004). Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control, 15, 465-72[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Karsenty, G, & Park, RW. (1995). Regulation of type I collagen genes expression. Int Rev Immunol, 12, 177-85[Medline] [Order article via Infotrieve] Kurttio, P, Pukkala, E, Kahelin, H, Auvinen, A, & Pekkanen, J. (1999). Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect, 107, 705-10[Web of Science][Medline] [Order article via Infotrieve] Kuznetsova, NV, Forlino, A, Cabral, WA, Marini, JC, & Leikin, S. (2004). Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model. Matrix Biol, 23, 101-12[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Li, M, Cai, JF, & Chiu, JF. (2002). Arsenic induces oxidative stress and activates stress gene expressions in cultured lung epithelial cells. J Cell Biochem, 87, 29-38[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Lynn, S, Gurr, JR, Lai, HT, & Jan, KY. (2000). NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res, 86, 514-19 Lynn, S, Lai, HT, Gurr, JR, & Jan, KY. (1997). Arsenite retards DNA break rejoining by inhibiting DNA ligation. Mutagenesis, 12, 353-58 Mazumder, DN. (2007). Arsenic and non-malignant lung disease. J Environ Sci Health A Tox Hazard Subst Environ Eng, 42, 1859-67[Web of Science][Medline] [Order article via Infotrieve] Nabi, AH, Rahman, MM, & Islam, LN. (2005). Evaluation of Biochemical Changes in Chronic Arsenic Poisoning among Bangladeshi Patients. Int J Environ Res Public Health, 2, 385-93[Medline] [Order article via Infotrieve] Rahman, MM, Chowdhury, UK, Mukherjee, SC, Mondal, BK, Paul, K, Lodh, D, Biswas, BK, Chanda, CR, Basu, GK, Saha, KC, Roy, S, Das, R, Palit, SK, Quamruzzaman, Q, & Chakraborti, D. (2001). Chronic arsenic toxicity in Bangladesh and West Bengal, India—a review and commentary. J Toxicol Clin Toxicol, 39, 683-700[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Rey, NA, Howarth, OW, & Pereira-Maia, EC. (2004). Equilibrium characterization of the As(III)-cysteine and the As(III)-glutathione systems in aqueous solution. J Inorg Biochem, 98, 1151-59[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Ross, JS, Stagliano, NE, Donovan, MJ, Breitbart, RE, & Ginsburg, GS. (2001). Atherosclerosis: a cancer of the blood vessels? Am J Clin Pathol, 116(Suppl), S97-S107[CrossRef][Medline] [Order article via Infotrieve] Saharinen, J, Hyytiainen, M, Taipale, J, & Keski-Oja, J. (1999). Latent transforming growth factor-beta binding proteins (LTBPs)—structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev, 10, 99-117[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Schwerdtle, T, Walter, I, & Hartwig, A. (2003). Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg. DNA Repair (Amst), 2, 1449-63[CrossRef][Medline] [Order article via Infotrieve] Simeonova, PP, Wang, S, Toriuma, W, Kommineni, V, Matheson, J, Unimye, N, Kayama, F, Harki, D, Ding, M, Vallyathan, V, & Luster, MI. (2000). Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res, 60, 3445-53 Soucy, NV, Ihnat, MA, Kamat, CD, Hess, L, Post, MJ, Klei, LR, Clark, C, & Barchowsky, A. (2003). Arsenic stimulates angiogenesis and tumorigenesis in vivo. Toxicol Sci, 76, 271-79 Soucy, NV, Klei, LR, Mayka, DD, & Barchowsky, A. (2004). Signaling pathways for arsenic-stimulated vascular endothelial growth factor-a expression in primary vascular smooth muscle cells. Chem Res Toxicol, 17, 555-63[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Spuches, AM, Kruszyna, HG, Rich, AM, & Wilcox, DE. (2005). Thermodynamics of the As(III)-thiol interaction: arsenite and monomethylarsenite complexes with glutathione, dihydrolipoic acid, and other thiol ligands. Inorg Chem, 44, 2964-72[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Steinmaus, C, Yuan, Y, Bates, MN, & Smith, AH. (2003). Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol, 158, 1193-201 Tchounwou, PB, Wilson, B, & Ishaque, A. (1999). Important considerations in the development of public health advisories for arsenic and arsenic-containing compounds in drinking water. Rev Environ Health, 14, 211-29[Medline] [Order article via Infotrieve] Tsai, SM, Wang, TN, & Ko, YC. (1999). Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch Environ Health, 54, 186-93[Web of Science][Medline] [Order article via Infotrieve] Tseng, CH. (2002). An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology, 53, 529-37[Web of Science][Medline] [Order article via Infotrieve] Tseng, CH, Chong, CK, Tseng, CP, Hsueh, YM, Chiou, HY, Tseng, CC, & Chen, CJ. (2003). Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol Lett, 137, 15-21[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Van Hoozen, BE, Grimmer, KL, Marelich, GP, Armstrong, LC, & Last, JA. (2000). Early phase collagen synthesis in lungs of rats exposed to bleomycin. Toxicology, 147, 1-13[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Wang, CH, Jeng, JS, Yip, PK, Chen, CL, Hsu, LI, Hsueh, YM, Chiou, HY, Wu, MM, & Chen, CJ. (2002). Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation, 105, 1804-9 Wang, SL, Chiou, JM, Chen, CJ, Tseng, CH, Chou, WL, Wang, CC, Wu, TN, & Chang, LW. (2003). Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. Environ Health Perspect, 111, 155-59[Web of Science][Medline] [Order article via Infotrieve] Wang, TS, Shu, YF, Liu, YC, Jan, KY, & Huang, H. (1997). Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology, 121, 229-37[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Whiteman, P, Hutchinson, S, & Handford, PA. (2006). Fibrillin-1 misfolding and disease. Antioxid Redox Signal, 8, 338-46[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Wu, CH, Walton, CM, & Wu, GY. (1991). Propeptide-mediated regulation of procollagen synthesis in IMR-90 human lung fibroblast cell cultures. Evidence for transcriptional control. J Biol Chem, 266, 2983-87 Yager, JW, & Wiencke, JK. (1997). Inhibition of poly(ADP-ribose) polymerase by arsenite. Mutat Res, 386, 345-51[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Yang, CY, Chiu, HF, Chang, CC, Ho, SC, & Wu, TN. (2005). Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan. Environ Res, 98, 127-32[Medline] [Order article via Infotrieve] Yang, P, He, XQ, Peng, L, Li, AP, Wang, XR, Zhou, JW, & Liu, QZ. (2007). The role of oxidative stress in hormesis induced by sodium arsenite in human embryo lung fibroblast (HELF) cellular proliferation model. J Toxicol Environ Health A, 70, 976-83[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Yeh, JY, Cheng, LC, Ou, BR, Whanger, DP, & Chang, LW. (2002). Differential influences of various arsenic compounds on glutathione redox status and antioxidative enzymes in porcine endothelial cells. Cell Mol Life Sci, 59, 1972-82[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Yih, LH, Peck, K, & Lee, TC. (2002). Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis, 23, 867-76 Yuan, SS, Hou, MF, Chang, HL, Chan, TF, Wu, YH, Wu, YC, & Su, JH. (2003). Arsenite-induced nitric oxide generation is cell cycle-dependent and aberrant in NBS cells. Toxicol In Vitro, 17, 139-43[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
This version was published on October
1, 2008 Toxicologic Pathology, Vol. 36, No. 6,
805-817 (2008)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

-smooth muscle actin in blood vessel walls was decreased in the AsIII-exposed animals. These data reveal a functional link between AsIII exposure and disruption in the vascular ECM. These AsIII-induced early pathological events may predispose humans to respiratory and cardiovascular diseases linked to chronic low-dose AsIII exposure. 




B depends on the integrity of the I